Exact Sciences Corporation (EXAS)
Mar 23, 2026 - EXAS was delisted (reason: acquired by ABT)
104.91
+0.99 (0.95%)
Inactive · Last trade price on Mar 20, 2026
Exact Sciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 956 | 600.89 | 605.38 | 242.49 | 315.47 |
Short-Term Investments | 8.72 | 437.14 | 172.27 | 389.56 | 715.01 |
Cash & Short-Term Investments | 964.71 | 1,038 | 777.64 | 632.06 | 1,030 |
Cash Growth | -7.06% | 33.48% | 23.03% | -38.66% | -43.99% |
Accounts Receivable | 298.65 | 248.97 | 203.62 | 158.04 | 216.65 |
Inventory | 166.2 | 162.38 | 127.48 | 118.26 | 104.99 |
Other Current Assets | 126.28 | 122.05 | 85.63 | 73.9 | 74.12 |
Total Current Assets | 1,556 | 1,571 | 1,194 | 982.26 | 1,426 |
Net Property, Plant & Equipment | 831 | 810.63 | 842.06 | 851.76 | 754.47 |
Other Intangible Assets | 919.93 | 1,010 | 1,890 | 1,956 | 2,094 |
Goodwill | 2,368 | 2,367 | 2,367 | 2,346 | 2,335 |
Other Long-Term Assets | 185.81 | 169.72 | 177.39 | 90.58 | 74.59 |
Total Assets | 5,861 | 5,928 | 6,471 | 6,227 | 6,685 |
Liabilities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 175.87 | 89.57 | 78.82 | 74.92 | 67.83 |
Accrued Expenses | 416.47 | 328.29 | 341.68 | 299.22 | 398.56 |
Current Portion of Long-Term Debt | - | 249.15 | 50 | - | - |
Current Portion of Leases | 33.59 | 27.41 | 29.38 | 28.37 | 19.71 |
Other Current Liabilities | 15.22 | 37.77 | 14.82 | 10.25 | 30.97 |
Total Current Liabilities | 641.15 | 732.19 | 514.7 | 412.75 | 517.07 |
Long-Term Debt | - | - | 2,314 | 2,236 | 2,180 |
Long-Term Leases | - | - | 161.07 | 182.4 | 182.17 |
Other Long-Term Liabilities | - | - | 335.98 | 352.46 | 417.78 |
Total Long-Term Liabilities | - | - | 2,811 | 2,771 | 2,780 |
Total Liabilities | 641.15 | 732.19 | 3,326 | 3,184 | 3,297 |
Shareholders' Equity
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | 1.82 | 1.78 | 1.74 |
Additional Paid-in Capital | - | - | 6,611 | 6,312 | 6,029 |
Accumulated Other Comprehensive Income | - | - | 1.43 | -5.24 | -1.44 |
Retained Earnings | - | - | -3,469 | -3,265 | -2,642 |
Shareholders' Equity | - | - | 3,145 | 3,043 | 3,388 |
Total Liabilities & Equity | 641.15 | 732.19 | 6,471 | 6,227 | 6,685 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 33.59 | 276.56 | 2,555 | 2,447 | 2,382 |
Net Cash (Debt) | 931.12 | 761.47 | -1,777 | -1,815 | -1,352 |
Net Cash Growth | 22.28% | - | - | - | - |
Net Cash Per Share | 4.93 | 4.13 | -9.87 | -10.29 | -7.89 |
Book Value | 0 | 0 | 3,145 | 3,043 | 3,388 |
Book Value Per Share | - | - | 17.46 | 17.26 | 19.77 |
Tangible Book Value | -3,288 | -3,376 | -1,112 | -1,259 | -1,042 |
Tangible Book Value Per Share | -17.43 | -18.33 | -6.17 | -7.14 | -6.08 |